FI803727L - 2,3-indolidionderivat - Google Patents

2,3-indolidionderivat

Info

Publication number
FI803727L
FI803727L FI803727A FI803727A FI803727L FI 803727 L FI803727 L FI 803727L FI 803727 A FI803727 A FI 803727A FI 803727 A FI803727 A FI 803727A FI 803727 L FI803727 L FI 803727L
Authority
FI
Finland
Prior art keywords
indolidionderivat
Prior art date
Application number
FI803727A
Other languages
English (en)
Inventor
Graham Alwyn Fothergill
John Merwyn Osbond
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI803727L publication Critical patent/FI803727L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI803727A 1979-12-07 1980-12-01 2,3-indolidionderivat FI803727L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942324 1979-12-07

Publications (1)

Publication Number Publication Date
FI803727L true FI803727L (fi) 1981-06-08

Family

ID=10509706

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803727A FI803727L (fi) 1979-12-07 1980-12-01 2,3-indolidionderivat

Country Status (16)

Country Link
US (1) US4395559A (fi)
EP (1) EP0030380A1 (fi)
JP (1) JPS5695167A (fi)
AR (1) AR226869A1 (fi)
AU (1) AU6494680A (fi)
DK (1) DK522180A (fi)
ES (1) ES497530A0 (fi)
FI (1) FI803727L (fi)
GR (1) GR72136B (fi)
HU (1) HU180620B (fi)
IL (1) IL61603A0 (fi)
MC (1) MC1357A1 (fi)
NO (1) NO803693L (fi)
NZ (1) NZ195702A (fi)
PT (1) PT72176B (fi)
ZA (1) ZA807494B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593106A (en) * 1984-06-04 1986-06-03 Smithkline Beckman Corporation 4-[2-(dialkylamino)ethyl]-7-hydroxyisatins
US4847863A (en) * 1985-10-03 1989-07-11 Watson Bruce W Expandable modular data modem
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1778174A (en) * 1926-05-30 1930-10-14 Gen Aniline Works Inc Substituted isatins and process of preparing them
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
CH472404A (de) * 1966-03-04 1969-05-15 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE379196B (fi) * 1971-06-24 1975-09-29 Sandoz Ag
US4137331A (en) * 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
US4212804A (en) * 1978-12-04 1980-07-15 Sandoz, Inc. Process for the preparation of optionally substituted 2,3-indolinediones

Also Published As

Publication number Publication date
ES8205770A1 (es) 1982-07-01
AU6494680A (en) 1981-06-11
HU180620B (en) 1983-03-28
US4395559A (en) 1983-07-26
GR72136B (fi) 1983-09-20
PT72176A (en) 1981-01-01
MC1357A1 (fr) 1981-08-10
JPS5695167A (en) 1981-08-01
ZA807494B (en) 1981-11-25
IL61603A0 (en) 1981-01-30
NZ195702A (en) 1984-09-28
NO803693L (no) 1981-06-09
DK522180A (da) 1981-06-08
ES497530A0 (es) 1982-07-01
AR226869A1 (es) 1982-08-31
PT72176B (en) 1982-07-05
EP0030380A1 (de) 1981-06-17

Similar Documents

Publication Publication Date Title
DK537780A (da) 1,8-naphthyridin-derivater
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
DK3881A (da) Substituerede 9,10-anthracen-bishydrazoner
FI793663A (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
SE7803411L (sv) 2,6-dialkoxibensamider
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
FI803727L (fi) 2,3-indolidionderivat
NO802888L (no) 2-klor-4,5-disubstituerte-thiazoler
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
NO793494L (no) Sylinderlaas i.
FI792047A (fi) Oktahydro-2h-pyrrolo/3,4-g/kinoliner
FI801473A (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE883295A (fr) 6,7-secoergolines
FI800736A (fi) 1,1'-difenyl-2-yl-alkylaminderivat
FI803038A (fi) Framstaellning av 2,5-diketoglukonsyra
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
BE881358A (fr) 25-hydroxycholecalciferol-26,23-lactone
FI803041A (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner
DK136379A (da) 4,6-dihalogensteroider
NO802405L (no) 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivater
DK446582A (da) 24,24-difluor-1alfa,15-dihydro-5,6-transcholecalciferol
DE2953592A1 (de) 24,24-difluoro-25-hydroxycholecalciferol
DK430479A (da) 2,6-dihalogenbensylestere
NO812109L (no) Z-profilfoeringsinnretning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO